Journal
CLINICS IN CHEST MEDICINE
Volume 36, Issue 4, Pages 751-+Publisher
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.ccm.2015.08.015
Keywords
Sarcoidosis; Treatment; Corticosteroids; Steroid sparing; TNF antagonists; Prognosis; Patient preferences
Categories
Funding
- Mallinkrodt Pharmaceuticals
Ask authors/readers for more resources
Treatment of sarcoidosis is not required in all patients with the diagnosis. The decision to treat and the strategy for how to treat usually require input and shared decision making by the patient. Some common consequences of sarcoidosis are not caused by granulomatous inflammation, but may be the dominant disease manifestation and should be actively considered when formulating a treatment plan. The medication regimen should be tailored to each patient. Steroid-sparing medications should be prescribed early as part of a long-term strategy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available